[HTML][HTML] Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression
I González-Martínez, E Cerro-Herreros… - … Therapy-Nucleic Acids, 2023 - cell.com
Myotonic dystrophy type 1 (DM1) is a rare neuromuscular disease caused by a CTG repeat
expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
[PDF][PDF] Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression
I González-Martínez, E Cerro-Herreros, N Moreno… - roderic.uv.es
Myotonic dystrophy type 1 (DM1) is a rare neuromuscular disease caused by a CTG repeat
expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
[HTML][HTML] Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression
I González-Martínez, E Cerro-Herreros… - Molecular Therapy …, 2023 - ncbi.nlm.nih.gov
Abstract Myotonic dystrophy type 1 (DM1) is a rare neuromuscular disease caused by a CTG
repeat expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
repeat expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression.
I González-Martínez, E Cerro-Herreros… - Molecular therapy …, 2023 - europepmc.org
Abstract Myotonic dystrophy type 1 (DM1) is a rare neuromuscular disease caused by a CTG
repeat expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
repeat expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
[PDF][PDF] Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression
I González-Martínez, E Cerro-Herreros, N Moreno… - researchgate.net
Myotonic dystrophy type 1 (DM1) is a rare neuromuscular disease caused by a CTG repeat
expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression
I González-Martínez… - Molecular therapy …, 2023 - pubmed.ncbi.nlm.nih.gov
Myotonic dystrophy type 1 (DM1) is a rare neuromuscular disease caused by a CTG repeat
expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
[HTML][HTML] Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression
I González-Martínez, E Cerro-Herreros… - … Therapy-Nucleic Acids, 2023 - Elsevier
Myotonic dystrophy type 1 (DM1) is a rare neuromuscular disease caused by a CTG repeat
expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
[PDF][PDF] Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression
I González-Martínez, E Cerro-Herreros, N Moreno… - roderic.uv.es
Myotonic dystrophy type 1 (DM1) is a rare neuromuscular disease caused by a CTG repeat
expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression.
I González-Martínez, E Cerro-Herreros… - Molecular therapy …, 2023 - europepmc.org
Myotonic dystrophy type 1 (DM1) is a rare neuromuscular disease caused by a CTG repeat
expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …
expansion in the DMPK gene that generates toxic RNA with a myriad of downstream …